Pulmonary hypertension in the clinic

Electronic Poster Discussion
Chairs: A. Vonk Noordegraaf (Aalsmeer, Netherlands), J. Barbera (Barcelona, Spain)

A multicenter case-control study of genetic risk factors for portopulmonary hypertension (POPH) S. Kawut, M. Krowka, K. Roberts, R. Benza, D. Taichman, D. Badesch, E. Horn, D. Rabinowitz, J. Trotter, L. Forman, R. Brown, M. Fallon (New York, NY, Rochester, MN, Boston, MA, Birmingham, AL, Philadelphia, PA, Denver, CO, United States Of America)
Prognostic factors in portopulmonary hypertension J. Le Pavec, R. Souza, K. Boutet, X. Jaïs, C. Tcherakian, M. Humbert, P. Hervé, G. Simonneau, O. Sitbon (Clamart, France)
New insight into the relationship between exhaled nitric oxide and pulmonary hemodynamics in cirrhotic patients B. Degano, H. Njima, N. Souletie, L. Tetu, J. Rami (Toulouse, France)
Hemodynamics in pulmonary hypertension associated to schistosomiasis C. Fernandes, C. Jardim, M. Lapa, A. Hovnanian, B. Dias, A. Breda, B. Martins, R. Souza (Sao Paulo, SP, Brazil)
Pulmonary veno-occlusive disease: clinical, functional and hemodynamic characteristics D. Montani, L. Achouh, A. Rabiller, R. Haque, P. Dorfmüller, F. Capron, O. Sitbon, X. Jaïs, G. Simonneau, M. Humbert (Clamart, Paris, France)
Veno-occlussive lesions and inflammation in pulmonary arterial hypertension associated with connective tissue diseases P. Dorfmuller, M. Humbert, F. Perros, O. Sanchez, G. Simonneau, F. Capron (Paris, Clamart, France)
Improved survival in pulmonary hypertension during pregnancy using vasodilator therapy and early elective delivery D. G. Kiely, C. A. Elliot, V. J. Webster, P. Stewart (Sheffield, United Kingdom)
Effects of treatment for pulmonary hypertension on pulmonary artery distensibility determined by cardiac magnetic resonance imaging L. McLure, A. Peacock (Glasgow, United Kingdom)
Serial brain natriuretic peptides track change in 6 minute walk distance in pulmonary arterial hypertension C. Carlin, K. Blyth, L. McLure, R. Spooner, A. Peacock, M. Johnson (Glasgow, United Kingdom)
NT-pro-BNP levels are independent of exercise in pulmonary hypertension S. A. van Wolferen, W. Jacobs, A. A. Bouman, H. Groepenhoff, A. Boonstra, P. E. Postmus, A. Vonk Noordegraaf (Amsterdam, Netherlands)
Surveillance of tunnelled central venous catheter infections in patients with pulmonary arterial hypertension (PAH) treated with i.v. iloprost J. De Soyza, R. Crackett, L. Mackay, J. Wilson, G. Parry, G. MacGowan, A. Fisher, J. Lordan, P. Corris (Newcastle upon Tyne, United Kingdom)
Objective quantification of right ventricular ejection fraction using new 3D echocardiographic software in patients with pulmonary arterial hypertension A. Filusch, S. Palma, R. Bartolles, H. A. Katus, J. Meyer (Heidelberg, Munich, Germany)
Pulmonary arterial hypertension among elderly patients: an emerging problem? I. Frachon, A. Barnier, C. Gut-Gobert, Y. Jobic, Y. Etienne, P. Mialon, C. Rogé, C. Leroyer, M. Humbert (Brest, Clamart, France)
Osteoporosis in patients with idiopathic and chronic thromboembolic pulmonary hypertension S. Ulrich, M. Hersberger, M. Fischler, C. Schmid, R. Speich (Zurich, Switzerland)
Cambridge pulmonary hypertension outcomes review (CAMPHOR) utility assessment in pulmonary hypertension (PH) patients D. Meads, S. McKenna, N. Doughty, J. Pepke-Zaba (Manchester, Cambridge, United Kingdom)
Quadriceps dysfunction in patients with pulmonary arterial hypertension F. S. de Man, B. J. van Beek-Harmsen, H. Groepenhoff, H. J. Bogaard, A. Boonstra, P. E. Postmus, A. Vonk-Noordegraaf, W. J. van der Laarse (Amsterdam, Netherlands)
Endothelin system, exhaled nitric oxide and high altitude pulmonary hypertension B. Kojonazarov, B. Imanov, M. Kochkorova, M. Mirrakhimov, N. Morrell, M. Wilkins, A. Aldashev (Bishkek, Kyrgyzstan; Cambridge, London, United Kingdom)
Role of nitric oxide pathway in pathogenesis of high altitude pulmonary hypertension A. Aldashev, B. Kojonazarov, B. Imanov, A. Maripov, M. Kochkorova, T. Sooronbaev, M. Mirrakhimov, N. Morrell, M. Wilkins (Bishkek, Kyrgyzstan; Cambridge, London, United Kingdom)
Pulmonary arterial hypertension associated with exposure to fenfluramine: a report of 109 cases R. Souza, M. Humbert, B. Sztrymf, X. Jais, A. Yaici, J. Le Pavec, F. Parent, P. Herve, F. Soubrier, O. Sitbon, G. Simonneau (Clamart, Paris, France)